The high number of COVID-19 recoveries in Japan has led to a shortage of patients to enroll in clinical trials, delaying work on potential treatments and vaccines for the disease.Original Article
Japan Faces New Challenge After Successful COVID-19 Fight: Patient Shortage For Clinical Trials
